Top compounds associated with response to FUS


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.016 0.7
mRNA lenalidomide GDSC1000 pan-cancer AAC 0.015 0.7
mRNA RO4929097 CTRPv2 pan-cancer AAC 0.022 0.7
mRNA QL-XII-47 GDSC1000 pan-cancer AAC 0.013 0.7
mRNA BIRB 0796 GDSC1000 pan-cancer AAC -0.014 0.7
mRNA HG-6-64-1 GDSC1000 pan-cancer AAC -0.014 0.7
mRNA DBeQ CTRPv2 pan-cancer AAC 0.014 0.7
mRNA SN-38 GDSC1000 pan-cancer AAC -0.013 0.7
mRNA Nutlin-3a (-) GDSC1000 pan-cancer AAC 0.013 0.7
mRNA CIL70 CTRPv2 pan-cancer AAC 0.018 0.7
Download CSV